IBA moves toward sale of Cisbio Bioassays

05/14/2013 | Reuters

Ion Beam Applications said it is in a tentative deal to sell its drug discovery unit Cisbio Bioassays to a private equity firm in Europe for $32.5 million. IBA said it is focusing on its core operations involving particle accelerators and radiation therapy. The deal is set to be completed in the coming months.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA